title: Clinical evaluation of combined therapy for type 2 diabetes.
authors.affiliation: Lilly Research Laboratories, Alcobendas, Spain. rodriguez_angel@lilly.com
authors.forename: Angel
authors.initials: A
authors.lastname: Rodríguez
authors.forename: Luis
authors.initials: L
authors.lastname: Ciprés
authors.forename: Santiago
authors.initials: S
authors.lastname: Tofé
authors.forename: Pepa
authors.initials: P
authors.lastname: Polavieja
authors.forename: Jesús
authors.initials: J
authors.lastname: Reviriego
mesh_terms: D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D000077205:Pioglitazone; D011446:Prospective Studies; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D014280:Triglycerides; D008687:Metformin; D002784:Cholesterol; D000077205:Pioglitazone